CD8A and non-Hodgkin lymphoma: Moreover, day 14 γδT cells from melanoma-unrelated patients (HL, NHL and CRC; see above) were also capable of cross-presenting influenza M1 p58–66 to CD8+ αβT responder cells (not shown).